Rainbow Children’s Medicare operating cash tops capital spend

Rainbow Children’s Medicare Limited generated Rs 217.768 crore in operating cash flow for the six months ended 30 September 2026, exceeding its Rs 138.170 crore reported capital-spending purchase line. The cash generation came as right-of-use assets increased Rs 61.161 crore and total lease liabilities rose Rs 77.239 crore from 31 March 2026.

How did Rainbow Children’s Medicare fund half-year capital spending?

Rainbow Children’s Medicare funded its Rs 138.170 crore purchase line for property, plant and equipment, other intangibles, intangible assets under development, capital advances, capital creditors and capital work-in-progress from Rs 217.768 crore of net operating cash flow. On that reported comparison, operating cash flow was Rs 79.598 crore higher than the capital-spending purchase line before other investing and financing movements.

Net cash generated from operating activities increased from Rs 207.587 crore in the six months ended 30 September 2025 to Rs 217.768 crore in the 2026 period. Cash generated from operations before tax payments rose Rs 24.570 crore to Rs 276.263 crore, but net income tax paid increased to Rs 58.495 crore from Rs 44.106 crore.

Profit before tax was Rs 195.457 crore, compared with Rs 173.744 crore a year earlier. The cash-flow reconciliation included Rs 86.803 crore of depreciation and amortisation, up from Rs 70.028 crore, and Rs 43.201 crore of finance cost, compared with Rs 36.927 crore in the corresponding prior-year period.

What working-capital movements affected Rainbow Children’s Medicare cash flow?

Rainbow Children’s Medicare had cash outflows of Rs 31.127 crore from higher trade receivables, Rs 12.064 crore from higher inventories and Rs 23.324 crore from increased financial and other assets in the half year. These movements reduced cash generated from operations despite the increase in profit before tax and non-cash depreciation charges.

The working-capital outflows were partly offset by a Rs 26.288 crore increase in trade payables, a Rs 5.149 crore increase in financial and current liabilities and a Rs 4.105 crore increase in provisions. In the six months ended September 2025, trade payables had increased by Rs 38.313 crore, which was Rs 12.025 crore more than the 2026-period increase.

The balance sheet showed trade receivables of Rs 133.414 crore at 30 September 2026, up from Rs 103.179 crore at 31 March 2026. Inventories increased to Rs 53.698 crore from Rs 41.634 crore over the same period, while trade payables other than dues to micro and small enterprises rose to Rs 112.068 crore from Rs 70.979 crore.

Which assets increased at Rainbow Children’s Medicare?

Rainbow Children’s Medicare reported property, plant and equipment of Rs 938.676 crore at 30 September 2026, up Rs 46.243 crore from Rs 892.433 crore at 31 March 2026. Capital work-in-progress increased Rs 27.159 crore to Rs 102.910 crore, while intangible assets under development rose Rs 7.266 crore to Rs 10.736 crore.

Right-of-use assets increased to Rs 730.342 crore from Rs 669.181 crore, a rise of Rs 61.161 crore. Goodwill rose Rs 10.582 crore to Rs 167.472 crore, and other intangible assets increased to Rs 38.953 crore from Rs 37.385 crore.

Total non-current assets reached Rs 2,191.831 crore, compared with Rs 2,111.988 crore at the March 2026 year-end. Current assets rose to Rs 766.724 crore from Rs 662.854 crore, led in part by other financial assets increasing to Rs 155.865 crore from Rs 50.643 crore, while mutual-fund investments declined to Rs 353.612 crore from Rs 404.495 crore.

Why did Rainbow Children’s Medicare lease liabilities rise?

Rainbow Children’s Medicare’s total lease liabilities rose Rs 77.239 crore to Rs 968.223 crore at 30 September 2026, alongside the Rs 61.161 crore increase in right-of-use assets. Non-current lease liabilities increased to Rs 938.629 crore from Rs 865.370 crore, and current lease liabilities rose to Rs 29.594 crore from Rs 25.614 crore.

The cash-flow statement recorded Rs 10.775 crore of payments of the principal portion of lease liabilities during the six months and Rs 43.202 crore of interest paid. It also included Rs 1.301 crore of payments toward lease registration charges and upfront lease premium within investing activities, but did not provide a separate breakdown of lease additions.

Non-current liabilities rose Rs 79.488 crore to Rs 1,004.218 crore from 31 March 2026, with the increase in non-current lease liabilities accounting for most of that movement. Total equity increased to Rs 1,735.874 crore from Rs 1,663.588 crore, including Rs 1,713.990 crore attributable to the company’s owners at 30 September 2026.

How did Rainbow Children’s Medicare investing and financing cash flows change?

Rainbow Children’s Medicare used Rs 86.947 crore in investing activities in the 2026 half year, compared with an outflow of Rs 124.806 crore a year earlier. The smaller net outflow reflected the lower Rs 138.170 crore capital-spending purchase line, compared with Rs 302.272 crore in the prior-year half year.

Mutual-fund redemptions of Rs 325.689 crore exceeded investments of Rs 272.995 crore by Rs 52.694 crore in the 2026 period. In the corresponding 2025 period, redemptions exceeded investments by Rs 157.003 crore, while bank deposits with maturities above three months produced a net inflow of Rs 3.393 crore in 2026 against a net outflow of Rs 1.884 crore a year earlier.

Financing activities used Rs 132.165 crore, compared with Rs 76.219 crore in the six months ended September 2025. The 2026 outflow included Rs 42.901 crore for treasury-share purchases and Rs 35.548 crore in dividends, while cash and cash equivalents declined Rs 1.344 crore to Rs 32.550 crore, compared with a Rs 6.562 crore increase in the prior-year period.

Conclusion

Rainbow Children’s Medicare generated operating cash flow that exceeded its reported half-year capital-spending purchase line by Rs 79.598 crore. At the same time, its asset base expanded through higher property, plant and equipment, capital work-in-progress and right-of-use assets, while lease liabilities increased by more than the recorded rise in right-of-use assets.

The next disclosed expansion matter to watch is the proposed children’s and women’s hospital at Malad, Mumbai. Rainbow Children’s Medicare executed transaction documents on 29 July 2026 for the project through Rainbow Women & Children’s Hospital Private Limited and diluted a 24% stake in that subsidiary; the filing does not state the project’s completion date or capital cost.